Jung J

ORCID: 0000-0003-3422-1744 · 8 papers in corpus · active 2018-2025

Study types

  • article 2

Condition tags

  • dysmenorrhea 1
  • adenomyosis 1
2025
BMC women's health ·doi:10.1186/s12905-025-03954-2

BackgroundCervical cancer is the second-most common cancer among Cambodian women, with an estimated 1274 new cases and 670 deaths annually. On October 5, 2023, the Cambodian government introduced HPV vaccination for 9-year-old girls into th…

2025
Nature communications ·doi:10.1038/s41467-025-57323-6

Cervical cancer is the fourth most common female cancer, with the uterine ectocervix being the most commonly affected site. However, cervical stem cells, their differentiation, and their regulation remain poorly understood. Here, we report …

2024
Medicina (Kaunas, Lithuania) ·doi:10.3390/medicina60122068

Background and Objectives: Autonomic nervous system (ANS) disorders are responsible for primary dysmenorrhea and are closely linked to the spine. This study aims to evaluate the effects of sacroiliac joint manipulation on the ANS and lower …

article 2023
Gynecology and minimally invasive therapy ·doi:10.4103/gmit.gmit_102_22

OBJECTIVES: Uterine fibroids and adenomyosis are common gynecological conditions that often require surgical treatment. Minimally invasive interventions such as ultrasound-guided high-intensity focused ultrasound (USgHIFU) are gaining popul…

2022
Journal of personalized medicine ·doi:10.3390/jpm12121996

The objective of the present pilot study is to compare operative outcomes between vaginal natural orifice transluminal endoscopic surgery (vNOTES) and single-port access (SPA) adnexectomy. Subjects were patients who underwent adnexectomy fo…

2021
Frontiers in oncology ·doi:10.3389/fonc.2021.737943

The BTK inhibitors ibrutinib and acalabrutinib are FDA-approved drugs for the treatment of B cell malignances. Both drugs have demonstrated clinical efficacy and safety profiles superior to chemoimmunotherapy regimens in patients with chron…

article 2020
The Journal of clinical endocrinology and metabolism ·doi:10.1210/clinem/dgaa939

OBJECTIVE: To evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of TU2670, a novel orally active, nonpeptide gonadotropin-releasing hormone (GnRH) antagonist administered to healthy female participants. METHODS: This…

2018
BioMed research international ·doi:10.1155/2018/9207153

Recent studies have shown that overexpression of metastasis-associated in colon cancer 1 (MACC1) is significantly associated with adverse prognoses of patients with different kinds of cancer. However, the exact survival effect of MACC1 on e…